toremifene
information and resources from the National Cancer Institute
NCI Thesaurus | toremifene
A nonsteroidal triphenylethylene antiestrogen. Chemically related to tamoxifen, toremifene is a selective estrogen receptor modulator (SERM). This agent binds competitively to estrogen receptors, thereby interfering with estrogen activity. Toremifene also has intrinsic estrogenic properties, which are manifested according to tissue type or species. NCI Thesaurus | toremifene
A nonsteroidal triphenylethylene antiestrogen. Chemically related to tamoxifen, toremifene is a selective estrogen receptor modulator (SERM). This agent binds competitively to estrogen receptors, thereby interfering with estrogen activity. Toremifene also has intrinsic estrogenic properties, which are manifested according to tissue type or species.
Fareston
Treatment of advanced breast cancer in postmenopausal women.
Orion Corp. May 29 1997
|
|
|
|
news articles
MacroArray Technologies to Present Data on a Urine-Based ... Mar 31, 2006
Yahoo! News (press release) GTx is conducting a pivotal Phase III clinical trial of ACAPODENE® (toremifene citrate) in a 20 mg dose for the prevention of prostate cancer in men with high ...
GTx, Inc. to Present at the 26th Annual SG Cowen Health Care ... Mar 3, 2006
PR Newswire (press release), GTx is developing ACAPODENE(R) (toremifene citrate), a selective estrogen receptor modulator, or SERM, in two separate clinical programs in men: first, a ...
GTx Reports Positive Phase III Trial Interim Analysis Results Dec 15, 2005
PR Newswire (press release), ADT) experienced highly statistically significant increases in bone mineral density (BMD) after one year of treatment with ACAPODENE(R) (toremifene citrate) 80 ...
GTx, Inc. to Present at the Lazard Capital Markets Annual Life ... Nov 23, 2005
PR Newswire (press release), GTx is developing ACAPODENE (toremifene citrate), a selective estrogen receptor modulator, or SERM, in two separate clinical programs in men: (1) a pivotal ...
|
|
